208 related articles for article (PubMed ID: 17065109)
1. Purine catabolism in advanced carotid artery plaque.
Felici C; Ciari I; Terzuoli L; Porcelli B; Setacci C; Giubbolini M; Marinello E
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1291-4. PubMed ID: 17065109
[TBL] [Abstract][Full Text] [Related]
2. Purine bases and atheromatous plaque.
Terzuoli L; Marinello E; Felici C; Frosi B; Setacci C; Giubbolini M; Porcelli B
Int J Immunopathol Pharmacol; 2004; 17(3 Suppl):31-3. PubMed ID: 16857104
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant status and purine bases in carotid artery plaque.
Ciari I; Terzuoli L; Porcelli B; Coppola MG; Marinello E
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):624-7. PubMed ID: 18600516
[TBL] [Abstract][Full Text] [Related]
4. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
[TBL] [Abstract][Full Text] [Related]
5. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
[TBL] [Abstract][Full Text] [Related]
6. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
J Rheumatol; 2001 Oct; 28(10):2294-7. PubMed ID: 11669172
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE.
Caussé E; Pradelles A; Dirat B; Negre-Salvayre A; Salvayre R; Couderc F
Electrophoresis; 2007 Feb; 28(3):381-7. PubMed ID: 17177243
[TBL] [Abstract][Full Text] [Related]
9. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens.
Carro MD; Falkenstein E; Radke WJ; Klandorf H
Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):12-7. PubMed ID: 19654053
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
11. Effect of glucagon on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of allantoin, uric acid, xanthine and hypoxanthine in blood by high-performance liquid chromatography.
Czauderna M; Kowalczyk J
J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):89-98. PubMed ID: 9518182
[TBL] [Abstract][Full Text] [Related]
13. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
Zitnanová I; Korytár P; Aruoma OI; Sustrová M; Garaiová I; Muchová J; Kalnovicová T; Pueschel S; Duracková Z
Clin Chim Acta; 2004 Mar; 341(1-2):139-46. PubMed ID: 14967170
[TBL] [Abstract][Full Text] [Related]
14. [The postnatal development of porcine purine catabolism and the effect of the environmental temperature on turnover].
Giesecke D; Heiss G; Pospischil A
Zentralbl Veterinarmed A; 1993 Aug; 40(6):401-11. PubMed ID: 8237173
[TBL] [Abstract][Full Text] [Related]
15. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
16. Purine metabolism of uric acid urolithiasis induced in newborn piglets.
Kakino J; Sato R; Naito Y
J Vet Med Sci; 1998 Feb; 60(2):203-6. PubMed ID: 9524944
[TBL] [Abstract][Full Text] [Related]
17. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation.
Marro PJ; Baumgart S; Delivoria-Papadopoulos M; Zirin S; Corcoran L; McGaurn SP; Davis LE; Clancy RR
Pediatr Res; 1997 Apr; 41(4 Pt 1):513-20. PubMed ID: 9098853
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
Torres RJ; Prior C; Puig JG
Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
[TBL] [Abstract][Full Text] [Related]
20. A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.
Reinders MK; Nijdam LC; van Roon EN; Movig KL; Jansen TL; van de Laar MA; Brouwers JR
J Pharm Biomed Anal; 2007 Oct; 45(2):312-7. PubMed ID: 17890037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
